SwissMedic-2021-0029-V029

Type II variation for application SwissMedic-2021-0029. Type II variation: Container Closure Change for Atezolimumab-R — routine update

Variation Number
SwissMedic-2021-0029-V029
Type
Type II
Application
SwissMedic-2021-0029
Change
CHG-2024-0029
Status
Failed
Fee
€37,770
Submitted
2022-08-18
Approved
—
Description

Type II variation: Container Closure Change for Atezolimumab-R — routine update